title: Palifermin dose should be adjusted to different therapy regimens.
authors.forename: M P M
authors.initials: MP
authors.lastname: Verhagen
authors.forename: M J
authors.initials: MJ
authors.lastname: Wondergem
authors.forename: O
authors.initials: O
authors.lastname: Visser
mesh_terms: D004334:Drug Administration Schedule; D005076:Exanthema / Q000209:etiology; D051523:Fibroblast Growth Factor 7 / Q000008:administration & dosage* / Q000009:adverse effects*; D006801:Humans; D008558:Melphalan / Q000008:administration & dosage*; D009020:Morphine / Q000627:therapeutic use; D009061:Mouth Mucosa / Q000187:drug effects; D052016:Mucositis / Q000209:etiology; D009101:Multiple Myeloma / Q000188:drug therapy*; D010146:Pain; D011994:Recombinant Proteins / Q000008:administration & dosage; D033581:Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods; D016896:Treatment Outcome
chemical_list: D011994:Recombinant Proteins; D051523:Fibroblast Growth Factor 7; D009020:Morphine; D008558:Melphalan